Text reminders for blood thinners in atrial fibrillation
Part of Heart & circulation clinical trials.
This study tests whether text message reminders can help people with atrial fibrillation take their blood thinner medication more consistently. If you have atrial fibrillation and take a blood thinner, this could help you stay on track with your treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with atrial fibrillation (a type of irregular heartbeat).
- You have been taking a blood thinner (like warfarin, rivaroxaban, apixaban, dabigatran, or edoxaban) for at least 3 months.
- You have a personal mobile phone that can receive text messages.
- You are able to read and understand Chinese.
- You are willing to participate and give your consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program that uses WeChat messages to help people with atrial fibrillation remember to take their blood-thinner medication. The goal is to see if reminding people to think about future benefits (things they look forward to) improves how regularly they take their medicine.
This trial tests if talking with a pharmacist helps people with atrial fibrillation remember to take their blood thinner medicine correctly. It may improve stroke prevention.
This trial tests a mobile education program on a smartphone to help you learn about and manage your atrial fibrillation. If found helpful, it could improve your symptoms and quality of life.
This study tests a new blood thinner to prevent strokes and blood clots in people with atrial fibrillation (a common heart rhythm problem). You may qualify if you have atrial fibrillation and at least one risk factor for stroke, or if you've never taken a blood thinner before.
This study looks at whether older adults with atrial fibrillation are taking the right dose of their blood thinner medicine. It aims to improve how doctors prescribe these medications in primary care.
This study tests whether using a smartwatch to track how much time your heart is in AFib each day can help guide treatment. It aims to see if keeping AFib episodes low leads to better outcomes.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.